Carnitine-acylcarnitine translocase deficiency (CACTD), a fatty acid oxidation defect (FAOD), can present in the neonatal period with non-specific findings and hypoglycemia. Here, SLC25A20 is linked to hyperinsulinemic hypoglycemia, familial, 4.